|EGF Receptor (D38B1) XP® Rabbit mAb 4267||20 µl||
||H M Mk||175||Rabbit IgG|
|EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb 3197||20 µl||
|EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb 2085||20 µl||
|ALK (D5F3®) XP® Rabbit mAb 3633||20 µl||
||H||220 (ALK), 80 (NPM-ALK), 117 (EML4-ALK v1), 86 (EML4-ALK v3)||Rabbit IgG|
|HER2/ErbB2 (D8F12) XP® Rabbit mAb 4290||20 µl||
||H M||185||Rabbit IgG|
|FGF Receptor 1 (D8E4) XP®Rabbit mAb 9740||20 µl||
||H M R Mk||92 , 120, 145||Rabbit IgG|
|ROS1 (D4D6®) Rabbit mAb 3287||20 µl||
||H||258, 110, 50-80||Rabbit IgG|
|Ret (E1N8X) XP® Rabbit mAb 14556||20 µl||
||H M||150, 175||Rabbit IgG|
|Met (D1C2) XP® Rabbit mAb 8198||20 µl||
||H||140, 170||Rabbit IgG|
|Anti-rabbit IgG, HRP-linked Antibody 7074||100 µl||
Monoclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding E746-A750del and L865 mutant sequences of human EGFR, Pro320 of human Ret protein, and residues near the carboxy terminus of human Met protein, or recombinant proteins specific to the carboxy terminus of human FGF receptor 1, human ALK, human ROS1, the amino terminus of human HER2/ErbB2, and the cytoplasmic domain of human EGF receptor.
Explore pathways + proteins related to this product.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.